These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15104380)

  • 1. Prolonged remission of severe Crohn's disease after fever and leukopenia caused by 6-mercaptopurine.
    Lobel EZ; Korelitz BI; Vakher K; Panagopoulos G
    Dig Dis Sci; 2004 Feb; 49(2):336-8. PubMed ID: 15104380
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.
    Park MS; Kim DH; Kim DH; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Dis Sci; 2015 Jan; 60(1):195-204. PubMed ID: 25239495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-cirrhotic portal hypertension due to 6-mercaptopurine use for Crohn's disease.
    Pola S; Boland BS; Lin GY; Kuo A; Sandborn WJ
    Dig Dis Sci; 2014 Jul; 59(7):1642-4. PubMed ID: 24535249
    [No Abstract]   [Full Text] [Related]  

  • 6. 6-Mercaptopurine in maintaining remission in Crohn's disease: An old friend becomes a new hero.
    Seidman EG
    Gastroenterology; 2000 Oct; 119(4):1158-60. PubMed ID: 11040202
    [No Abstract]   [Full Text] [Related]  

  • 7. TPMT in the treatment of Crohn's disease with azathioprine.
    Lennard L
    Gut; 2002 Aug; 51(2):143-6. PubMed ID: 12117866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine and 6 Mercaptopurine in postoperative maintenance of Crohn's disease remission: is no evidence of effect an evidence of no effect?
    Mardini HE
    Gastroenterology; 2005 Jan; 128(1):246-8; author reply 248-9. PubMed ID: 15633153
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute myeloblastic leukemia following prolonged treatment of Crohn's disease with 6-mercaptopurine.
    Heizer WD; Peterson JL
    Dig Dis Sci; 1998 Aug; 43(8):1791-3. PubMed ID: 9724170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella zoster meningoradiculitis in Crohn's disease treated with 6-mercaptopurine.
    Cullen G; Krakower D; Mitty JA; Cheifetz AS
    Inflamm Bowel Dis; 2011 Aug; 17(8):E109-10. PubMed ID: 21618366
    [No Abstract]   [Full Text] [Related]  

  • 11. Eruptive benign melanocytic naevi during immunosuppressive therapy in a Crohn's disease patient.
    de Boer NK; Kuyvenhoven JP
    Inflamm Bowel Dis; 2011 Jun; 17(6):E26. PubMed ID: 21287668
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease.
    Colonna T; Korelitz BI
    Am J Gastroenterol; 1994 Mar; 89(3):362-6. PubMed ID: 8122645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
    Jacobstein DA; Baldassano RN
    Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease.
    Rosen R; Integlia MJ; Bousvaros A
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):695-9. PubMed ID: 12454589
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease.
    Markowitz J; Grancher K; Kohn N; Lesser M; Daum F
    Gastroenterology; 2000 Oct; 119(4):895-902. PubMed ID: 11040176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
    Griffiths AM
    Inflamm Bowel Dis; 2005 Feb; 11(2):200-2. PubMed ID: 15677915
    [No Abstract]   [Full Text] [Related]  

  • 17. Azathioprine-induce acute submandibular sialadenitis in a patient with Crohn's disease.
    Guerra Romero A; Pérez Calle JL; López Serrano P
    Gastroenterol Hepatol; 2018 Nov; 41(9):570-571. PubMed ID: 29150359
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate in patients with Crohn's disease after 6-mercaptopurine.
    Mack DR; Young R; Kaufman SS; Ramey L; Vanderhoof JA
    J Pediatr; 1998 May; 132(5):830-5. PubMed ID: 9602195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
    Hyams JS
    Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term immunosuppressive treatment in Crohn's disease.
    Nyman M; Hansson I; Eriksson S
    Scand J Gastroenterol; 1985 Dec; 20(10):1197-203. PubMed ID: 3912958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.